Stocksigma LogoStocksigma Logo

Krsnaa Diagnostics Reports Robust Q2 FY27 Topline Growth of 32% YoY

Krsnaa Diagnostics delivered strong performance for Q2 FY27, with revenue growing 32% YoY to INR 2,710 mn, driven by an 85% YoY surge in tests performed

Krsnaa Diagnostics Reports Robust Q2 FY27 Topline Growth of 32% YoY

Krsnaa Diagnostics Ltd 路 Investor Presentation 路 03 Nov 2026, 12:16 am

Krsnaa Diagnostics Reports Robust Q2 FY27 Topline Growth of 32% YoY Krsnaa Diagnostics delivered strong performance for Q2 FY27, with revenue growing 32% YoY to INR 2,710 mn, driven by an 85% YoY surge in tests performed (30.3 mn) and a 35% YoY increase in patients served (7.3 mn). Retail revenue rose 35% YoY to INR 235 mn. EBITDA (pre-CSR/ESOP) increased 20% YoY to INR 719 mn, while margins contracted 200 bps to 27% due to upfront fixed costs for Rajasthan labs. PAT rose 3% YoY to INR 246 mn. For H1 FY27, revenue reached INR 5,065 mn.

Original exchange filing (PDF)

More announcements from Krsnaa Diagnostics Ltd

All Krsnaa Diagnostics Ltd announcements